Jean-Ehrland Ricci

Jean-Ehrland Ricci

Auto-generated profile, based on publicly available information

Jean-Ehrland Ricci

Université Côte d’Azur, INSERM, C3M, Nice, France

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2003 in Molecular Cell
Verified
Journal Article
Closed access
KBKelly M Boatright
Kelly M Boatright
MRMartin Renatus
Martin Renatus
FSFiona L Scott
Fiona L Scott
SSSabina Sperandio
Sabina Sperandio
HSHwain Shin
Hwain Shin
GSGuy S Salvesen
Guy S Salvesen

2 September 2014 in OncoImmunology
Verified
Journal Article
Closed access
OKOliver Kepp
Oliver Kepp
LSLaura SENOVILLA
Laura SENOVILLA
IVIlio Vitale
Ilio Vitale
EVErika Vacchelli
Erika Vacchelli
SASandy Adjemian
Sandy Adjemian
Lorenzo GalluzziLorenzo Galluzzi
Lorenzo Galluzzi
Apoptotic cells have long been considered as intrinsically tolerogenic or unable to elicit immune responses specific for dead cell-associated antigens. However, multiple stimuli can trigger a functionally peculiar type of apoptotic demise that does not go unnoticed by the adaptive arm of the immune system, which we named “immunogenic cell death” (ICD). ICD is preceded or accompanied by the emission of a series of immunostimulatory damage-associated molecular patterns (DAMPs) in a precise spatiotemporal configuration. Several anticancer agents that have been successfully employed in the clinic for decades, including various chemotherapeutics and radiotherapy, can elicit ICD. Moreover, defects in the components that underlie the capacity of the immune system to perceive cell death as immunogenic negatively influence disease outcome among cancer patients treated with ICD inducers. Thus, ICD has profound clinical and therapeutic implications. Unfortunately, the gold-standard approach to detect ICD relies on vaccination experiments involving immunocompetent murine models and syngeneic cancer cells, an approach that is incompatible with large screening campaigns. Here, we outline strategies conceived to detect surrogate markers of ICD in vitro and to screen large chemical libraries for putative ICD inducers, based on a high-content, high-throughput platform that we recently developed. Such a platform allows for the detection of multiple DAMPs, like cell surface-exposed calreticulin, extracellular ATP and high mobility group box 1 (HMGB1), and/or the processes that underlie their emission, such as endoplasmic reticulum stress, autophagy and necrotic plasma membrane permeabilization. We surmise that this technology will facilitate the development of next-generation anticancer regimens, which kill malignant cells and simultaneously convert them into a cancer-specific therapeutic vaccine.

1 July 2008 in Immunity
Verified
Journal Article
Closed access
HKHirotaka Kazama
Hirotaka Kazama
JRJean-Ehrland Ricci
Jean-Ehrland Ricci
JHJohn M. Herndon
John M. Herndon
GHGeorge Hoppe
George Hoppe
DGDouglas R. Green
Douglas R. Green
TFThomas A. Ferguson
Thomas A. Ferguson

1 June 2004 in Cell
Verified
Journal Article
Closed access
JRJean-Ehrland Ricci
Jean-Ehrland Ricci
Cristina Muñoz-PinedoCristina Muñoz-Pinedo
Cristina Muñoz-Pinedo
PFPatrick Fitzgerald
Patrick Fitzgerald
BBBéatrice Bailly-Maitre
Béatrice Bailly-Maitre
GPGuy A Perkins
Guy A Perkins
DGDouglas R Green
Douglas R Green

1 June 2007 in Cell
Verified
Journal Article
Closed access
Anna ColellAnna Colell
Anna Colell
JRJean-Ehrland Ricci
Jean-Ehrland Ricci
STStephen Tait
Stephen Tait
SMSandra Milasta
Sandra Milasta
UMUlrich Maurer
Ulrich Maurer
DGDouglas R. Green
Douglas R. Green

6 January 2003 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
JRJean-Ehrland Ricci
Jean-Ehrland Ricci
RGRoberta A. Gottlieb
Roberta A. Gottlieb
DGDouglas R. Green
Douglas R. Green
During apoptosis, the permeabilization of the mitochondrial outer membrane allows the release of cytochrome c, which induces caspase activation to orchestrate the death of the cell. Mitochondria rapidly lose their transmembrane potential (ΔΨm) and generate reactive oxygen species (ROS), both of which are likely to contribute to the dismantling of the cell. Here we show that both the rapid loss of ΔΨm and the generation of ROS are due to the effects of activated caspases on mitochondrial electron transport complexes I and II. Caspase-3 disrupts oxygen consumption induced by complex I and II substrates but not that induced by electron transfer to complex IV. Similarly, ΔΨm generated in the presence of complex I or II substrates is disrupted by caspase-3, and ROS are produced. Complex III activity measured by cytochrome c reduction remains intact after caspase-3 treatment. In apoptotic cells, electron transport and oxygen consumption that depends on complex I or II was disrupted in a caspase-dependent manner. Our results indicate that after cytochrome c release the activation of caspases feeds back on the permeabilized mitochondria to damage mitochondrial function (loss of ΔΨm) and generate ROS through effects of caspases on complex I and II in the electron transport chain.